Abstracted Scientific Content
Volume 5 / Year 2016 / Issue 4
Strategies used to delay or prevent access to affordable generic drugs in the US
Page: 188
Submitted: 28 November 2016; Revised: 29 November 2016; Accepted: 30 November 2016; Published online first: 5 December 2016 In the journal Blood, Jones et al. [1] discuss strategies used by… Read More »
An empirical study of market-based purchasing policies for generic pharmaceuticals in Sweden
Page: 187
Submitted: 1 December 2016; Revised: 6 December 2016; Accepted: 7 December 2016; Published online first: 12 December 2016 In Sweden, the government funds an insurance programme covering 75–80% of the… Read More »
Essential information for internists on biologicals and biosimilars
Page: 186-7
Submitted: 21 November 2016; Revised: 22 November 2016; Accepted: 24 November 2016; Published online first: 30 November 2016 Authors from the IRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan,… Read More »
Effect of naming on pharmacists’ perceptions and dispensing of biosimilars
Page: 185
Submitted: 21 November 2016; Revised: 22 November 2016; Accepted: 24 November 2016; Published online first: 30 November 2016 A study of pharmacists investigated their perceptions of biosimilar naming conventions and… Read More »